Latest Fragile X Clinical Trial and Research Updates | May 2024 Webinar

Welcome to Part 2 of our FRAXA Research Q&A Webinar series held on May 23, 2024. In this segment, ongoing Fragile X clinical trials and we delve deeper into the latest research.

This recording features Dr. Michael Tranfaglia, MD, Medical Director and Co-Founder of FRAXA, who shares his expert insights alongside Katie Clapp, Co-Founder and President of FRAXA. We cover important updates on the Harmony Biosciences (Zynerba) Phase 3 Clinical Trial (RECONNECT) and the Tetra Therapeutics Phase 3 Clinical Trial of Zatolmilast. The session concludes with a quick Q&A addressing community questions.

Highlights
-- In-depth updates on the RECONNECT trial by Harmony Biosciences (Zynerba): Learn about the Phase 3 clinical trial, which includes an innovative at-home option for participants.
-- Tetra Therapeutics Phase 3 Clinical Trial of Zatolmilast: Gain insights into this significant trial by Tetra Therapeutics, a Shionogi Group Company, and its implications for Fragile X syndrome treatment.
-- Q&A Session: Engage with the interactive question-and-answer session where Dr. Michael Tranfaglia and Katie Clapp address questions from the community.

Subscribe to our channel for more videos on Fragile X research and clinical trials, and visit our website at FRAXA.org for more resources and information.

FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.

Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.

To learn more about FRAXA's Fragile X syndrome research, to get involved with Fragile X awareness and events or to donate to FRAXA research, visit www.fraxa.org

Let's Connect
Facebook:   / fraxaresearch  
Instagram:   / fraxaresearch  
LinkedIn:   / fraxa-research-foundation  
Reddit:   / fragilexreseach  
Website: https://www.fraxa.org